Distance from designated VA liver transplant center linked with greater risk of death

March 25, 2014

Veterans with liver disease who live more than 100 miles from a Veterans Administration hospital that offers liver transplants are only half as likely to be placed on the liver transplant waitlist to receive a new organ compared to veterans who live closer to transplant centers, according to a new study from the Perelman School of Medicine of the University of Pennsylvania. The findings, which are published in the March 26 issue of JAMA, also reveal that the further liver disease patients live from these five transplant centers, the more likely they are to die.

"Our study is the first to show that while the VA model of centralized healthcare might serve to control costs, concentrate specialized expertise, and minimize regional differences in the quality of care provided, it actually has negative consequences for many veterans," says David Goldberg, MD, MSCE, an instructor of Medicine at the Perelman School of Medicine of the University of Pennsylvania and lead author of the new study. "Increased travel time to a transplant center likely prevents patients from being evaluated for transplantation, and thus ultimately making it onto the waitlist. Among the subset that are waitlisted, increased distance is associated with decreased transplant rates, most likely because those patients at greater distances are unable to travel to the designated center quickly enough to receive a transplant after an organ becomes available. Our findings show that this distance places patients who live far away at a disadvantage that may put their lives at risk."

The VA system currently centralizes liver transplant care to five transplant centers (VATCs) nationwide, located in Houston, TX; Nashville, TN; Pittsburgh, PA; Portland, OR; and Richmond, VA. Patients who are insured through VA insurance and require liver transplant services must receive care at one of these five centers. The centralization of liver transplant care within the VA health system serves as a unique model to study the association between geography on access to specialized healthcare offered at a limited number of centers using a well-characterized national sample of patients in need of the service.

The Penn team conducted a retrospective review of 50,637 liver transplant-eligible veterans who received care between January 2003 to December 2010, using the Veterans' Health Administration (VHA) Corporate Data Warehouse. The data were linked to a national data repository of patients waitlisted for liver transplantation, managed by the United Network for Organ Sharing (UNOS).

Researchers found that there were significant differences in access to waitlisting depending on distance from a transplant center. For each doubling in distance from local VA hospital to VA transplant center (i.e. 50 vs 100 miles), there was a 9 percent decreased likelihood of being waitlisted at a VA transplant center.

Among veterans with severe , 7 percent of those within 100 miles were waitlisted at a VA transplant center, compared with 3 percent among those greater than 100 miles from a VA transplant center. These differences persisted even when accounting for those veterans who were waitlisted at their local, non-VA transplant center.

Among waitlisted veterans, distance appeared to be related to their chances of ultimately getting a transplant, with 64 percent of veterans who lived within 100 miles of that VA transplant center undergoing the surgery, compared with less than 55 percent of those living beyond 100 miles.

These differences in access to waitlisting and transplantation ultimately impacted survival, with increasing distance from a VA transplant center being associated with significantly increased risks of dying. Specifically, five-year survival rates from the date of being diagnosed with end-stage liver disease were 58 percent for veterans living within 100 miles of a VA transplant center, compared with less than 45 percent for greater than 300 miles away.

"Patients waitlisted at a VA transplant center must relocate with a primary support person for at least one month post-transplant unless they live within reasonable driving distance, placing those without the resources or ability to relocate their family and/or a support person at a disadvantage," said the study's senior author, David Kaplan, MD, an Assistant Professor of Medicine and Director of Hepatology at the Philadelphia VA Medical Center.

Unlike many geographic disparities in health care that are linked to rural areas – distance to trauma centers and advanced stroke care, for instance, have been shown to be greatest in rural areas – even VA patients in urban areas are impacted by the current structure of the VA transplant centers. The Pittsburgh VA transplant center, for instance, is the closest VA to the New York Metropolitan area, yet is greater than 300 miles from New York City. Patients in closer proximity to these centers are also more available to serve as backup recipients, in the event the intended recipient falls through, the study points out.

While the VA National Transplant Program is helping to mitigate disparities in access by approving the opening of two new VA centers, the authors do not believe this will fully alleviate geographic differences in access to transplantation. Drs. Goldberg, Kaplan and colleagues suggest several potential mechanisms to improve access and mitigate these disadvantages of distance, including using telehealth, deputizing local provider teams to perform initial waitlisting evaluations, streamlining referral to VA transplant centers, or lowering financial disincentives for access to local transplant services.

Explore further: Some receive unnecessary prioritization for liver transplantation, study says

More information: Paper doi:10.1001/jama.2014.2520

Related Stories

Some receive unnecessary prioritization for liver transplantation, study says

February 5, 2014
Patients waiting for liver transplants who develop hepatopulmonary syndrome (HPS), a lung disorder associated with end-stage liver disease, are eligible to move up on the wait list. In a new paper published in Gastroenterology, ...

Standardized evaluation consent forms for living liver donors needed

March 13, 2014
New research reveals that 57% of liver transplant centers use living donor evaluation consent forms that include all the elements required by the Centers for Medicare and Medicaid Services (CMS) and 78% of centers addressed ...

Liver transplant survival rates lower in black than white pediatric patients

December 5, 2013
Novel research reveals racial and socioeconomic disparities among pediatric liver transplant patients. Findings published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and ...

Alcoholism treatment before, after liver transplantation reduces relapse

October 3, 2013
New research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relapse rates than those untreated or only treated prior to transplantation. ...

Muscle loss ups mortality and sepsis risk in liver transplant candidates

February 13, 2014
Japanese researchers have determined that sarcopenia—a loss of skeletal muscle mass—increases risk of sepsis and mortality risk in patients undergoing live donor liver transplantation. Findings published in Liver Transplantation, ...

Morbidity higher in obese liver transplant recipients with diabetes, survival not impacted

January 23, 2014
Researchers from New Zealand report that morbidity following liver transplant is highest among obese patients with diabetes, but these risk factors do not influence post-transplant survival. According to the study published ...

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.